Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Korro Bio (KRRO) Other Working Capital Changes (2019 - 2025)

Korro Bio's Other Working Capital Changes history spans 7 years, with the latest figure at -$1.8 million for Q4 2025.

  • For the quarter ending Q4 2025, Other Working Capital Changes fell 286.09% year-over-year to -$1.8 million, compared with a TTM value of -$1.6 million through Dec 2025, down 319.01%, and an annual FY2025 reading of -$1.6 million, down 319.01% over the prior year.
  • Other Working Capital Changes for Q4 2025 was -$1.8 million at Korro Bio, down from -$250000.0 in the prior quarter.
  • The five-year high for Other Working Capital Changes was $3.2 million in Q4 2022, with the low at -$13.7 million in Q2 2021.
  • Average Other Working Capital Changes over 5 years is -$876705.9, with a median of -$124000.0 recorded in 2023.
  • Year-over-year, Other Working Capital Changes crashed 1605.84% in 2021 and then surged 9380.0% in 2024.
  • Tracing KRRO's Other Working Capital Changes over 5 years: stood at -$13.7 million in 2021, then soared by 123.46% to $3.2 million in 2022, then tumbled by 95.75% to $137000.0 in 2023, then skyrocketed by 597.81% to $956000.0 in 2024, then plummeted by 286.09% to -$1.8 million in 2025.
  • Per Business Quant, the three most recent readings for KRRO's Other Working Capital Changes are -$1.8 million (Q4 2025), -$250000.0 (Q3 2025), and $33000.0 (Q2 2025).